Literature DB >> 34979033

Anxiety in Angelman Syndrome.

Stacey C Grebe1, Danica L Limon1, Morgan M McNeel1, Andrew Guzick1, Sarika U Peters2, Wen-Hann Tan3, Anjali Sadhwani3, Carlos A Bacino4, Lynne M Bird5, Rodney C Samaco6, Leandra N Berry7, Wayne K Goodman8, Sophie C Schneider9, Eric A Storch9.   

Abstract

Angelman Syndrome (AS) is a neurodevelopmental disorder most commonly caused by the impaired expression of the maternal UBE3A gene on chromosome 15. Though anxiety has been identified as a frequently present characteristic in AS, there are limited studies examining anxiety in this population. Studies of anxiety in other neurodevelopmental disorders have found disorder specific symptoms of anxiety and age specific displays of anxiety symptoms. However, there is a consistent challenge in identifying anxiety in people with neurodevelopmental disorders given the lack of measurement instruments specifically designed for this population. Given the limited information about AS and anxiety, the aims of the current project were to (a) examine symptoms of anxiety in children with AS and (b) determine the correlates of anxiety in children with AS. Participants included 42 adult caregivers of youth with AS in the AS Natural History study who completed the Developmental Behavior Checklist (DBC). The results found that 26% of the sample demonstrated elevated symptoms of anxiety and established a relationship between elevated anxiety in youth with AS and higher levels of irritability, hyperactivity, self-absorbed behaviors, and disruptive/antisocial behaviors. Findings from this research provide a foundation for tailoring evidence-based assessments and treatments for youth with AS and anxiety. ©AAIDD.

Entities:  

Keywords:  Angelman syndrome; anxiety; children; developmental behavior checklist

Mesh:

Year:  2022        PMID: 34979033      PMCID: PMC8803540          DOI: 10.1352/1944-7558-127.1.1

Source DB:  PubMed          Journal:  Am J Intellect Dev Disabil        ISSN: 1944-7558


  36 in total

1.  Angelman syndrome 2005: updated consensus for diagnostic criteria.

Authors:  Charles A Williams; Arthur L Beaudet; Jill Clayton-Smith; Joan H Knoll; Martin Kyllerman; Laura A Laan; R Ellen Magenis; Ann Moncla; Albert A Schinzel; Jane A Summers; Joseph Wagstaff
Journal:  Am J Med Genet A       Date:  2006-03-01       Impact factor: 2.802

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

Review 3.  Angelman syndrome: Current and emerging therapies in 2016.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Am J Med Genet C Semin Med Genet       Date:  2016-11-08       Impact factor: 3.908

4.  Cortisol profiles differentiated in adolescents and young adult males with fragile X syndrome versus autism spectrum disorder.

Authors:  Sara M Matherly; Jessica Klusek; Angela J Thurman; Andrea McDuffie; Leonard Abbeduto; Jane E Roberts
Journal:  Dev Psychobiol       Date:  2017-11-24       Impact factor: 3.038

5.  Profiles and development of adaptive behavior in children with Down syndrome.

Authors:  E M Dykens; R M Hodapp; D W Evans
Journal:  Am J Ment Retard       Date:  1994-03

6.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

Authors:  M G Aman; N N Singh; A W Stewart; C J Field
Journal:  Am J Ment Defic       Date:  1985-03

7.  Associations between repetitive questioning, resistance to change, temper outbursts and anxiety in Prader-Willi and Fragile-X syndromes.

Authors:  K Woodcock; C Oliver; G Humphreys
Journal:  J Intellect Disabil Res       Date:  2008-09-03

Review 8.  Unmet clinical needs and burden in Angelman syndrome: a review of the literature.

Authors:  Anne C Wheeler; Patricia Sacco; Raquel Cabo
Journal:  Orphanet J Rare Dis       Date:  2017-10-16       Impact factor: 4.123

Review 9.  Anxiety Disorders in Williams Syndrome Contrasted with Intellectual Disability and the General Population: A Systematic Review and Meta-Analysis.

Authors:  R Royston; P Howlin; J Waite; C Oliver
Journal:  J Autism Dev Disord       Date:  2017-12

10.  Risk of Depression and Anxiety in Adults With Cerebral Palsy.

Authors:  Kimberley J Smith; Mark D Peterson; Neil E O'Connell; Christina Victor; Silvia Liverani; Nana Anokye; Jennifer M Ryan
Journal:  JAMA Neurol       Date:  2019-03-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.